Cullen/Frost Bankers, Inc. Novartis Ag Transaction History

Cullen/Frost Bankers, Inc.

  • $7.23 Billion
  • Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 10,374 shares of NVS stock, worth $1.08 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,374
Previous 10,721 3.24%
Holding current value
$1.08 Million
Previous $1.14 Million 4.56%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$106.13 - $120.89 $36,827 - $41,948
-347 Reduced 3.24%
10,374 $1.19 Million
Q2 2024

Aug 05, 2024
SELL
$92.57 - $107.37 $136,448 - $158,263
-1,474 Reduced 12.09%
10,721 $1.14 Million
Q1 2024

May 10, 2024
BUY
$95.27 - $108.47 $10,193 - $11,606
107 Added 0.89%
12,195 $1.18 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $993,655 - $1.09 Million
-10,769 Reduced 47.11%
12,088 $1.22 Million
Q3 2023

Nov 02, 2023
BUY
$94.73 - $105.13 $36,565 - $40,580
386 Added 1.72%
22,857 $2.33 Million
Q2 2023

Aug 04, 2023
SELL
$92.52 - $104.91 $73,368 - $83,193
-793 Reduced 3.41%
22,471 $2.27 Million
Q1 2023

May 05, 2023
SELL
$80.03 - $92.81 $189,030 - $219,217
-2,362 Reduced 9.22%
23,264 $2.14 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $323,731 - $396,448
-4,285 Reduced 14.33%
25,626 $2.32 Million
Q3 2022

Nov 07, 2022
BUY
$74.61 - $87.26 $16,414 - $19,197
220 Added 0.74%
29,911 $2.27 Million
Q2 2022

Aug 05, 2022
SELL
$80.52 - $93.75 $26,088 - $30,375
-324 Reduced 1.08%
29,691 $2.51 Million
Q1 2022

May 09, 2022
SELL
$80.11 - $90.62 $108,549 - $122,790
-1,355 Reduced 4.32%
30,015 $2.63 Million
Q4 2021

Feb 07, 2022
SELL
$79.7 - $88.13 $68,462 - $75,703
-859 Reduced 2.67%
31,370 $2.74 Million
Q3 2021

Nov 04, 2021
SELL
$81.78 - $95.14 $132,401 - $154,031
-1,619 Reduced 4.78%
32,229 $2.64 Million
Q2 2021

Aug 05, 2021
SELL
$85.24 - $94.15 $426 - $470
-5 Reduced 0.01%
33,848 $3.09 Million
Q1 2021

May 05, 2021
SELL
$83.5 - $98.47 $473,528 - $558,423
-5,671 Reduced 14.35%
33,853 $2.89 Million
Q4 2020

Feb 08, 2021
SELL
$78.07 - $94.43 $96,260 - $116,432
-1,233 Reduced 3.03%
39,524 $3.73 Million
Q3 2020

Nov 05, 2020
BUY
$82.14 - $91.0 $269,172 - $298,207
3,277 Added 8.74%
40,757 $3.54 Million
Q2 2020

Aug 05, 2020
BUY
$80.93 - $91.1 $78,987 - $88,913
976 Added 2.67%
37,480 $3.27 Million
Q1 2020

May 01, 2020
SELL
$70.67 - $99.01 $102,471 - $143,564
-1,450 Reduced 3.82%
36,504 $3.01 Million
Q4 2019

Feb 06, 2020
SELL
$84.35 - $95.37 $1.49 Million - $1.69 Million
-17,685 Reduced 31.79%
37,954 $3.59 Million
Q3 2019

Nov 01, 2019
SELL
$85.54 - $94.26 $524,616 - $578,096
-6,133 Reduced 9.93%
55,639 $4.84 Million
Q2 2019

Aug 01, 2019
SELL
$75.4 - $92.8 $10.5 Million - $12.9 Million
-138,723 Reduced 69.19%
61,772 $5.64 Million
Q1 2019

Apr 30, 2019
BUY
$75.32 - $86.15 $1.99 Million - $2.28 Million
26,409 Added 15.17%
200,495 $19.2 Million
Q4 2018

Feb 06, 2019
SELL
$73.66 - $82.02 $4.82 Million - $5.36 Million
-65,401 Reduced 27.31%
174,086 $14.9 Million
Q3 2018

Oct 29, 2018
SELL
$66.94 - $77.43 $1.17 Million - $1.35 Million
-17,495 Reduced 6.81%
239,487 $20.6 Million
Q2 2018

Jul 27, 2018
SELL
$64.91 - $73.36 $1.01 Million - $1.14 Million
-15,509 Reduced 5.69%
256,982 $19.4 Million
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $1.04 Million - $1.24 Million
14,705 Added 5.7%
272,491 $22 Million
Q4 2017

Jan 31, 2018
BUY
$72.33 - $77.64 $328,450 - $352,563
4,541 Added 1.79%
257,786 $21.6 Million
Q3 2017

Nov 02, 2017
BUY
$74.14 - $77.27 $18.8 Million - $19.6 Million
253,245
253,245 $21.7 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email